ARTIFICIAL INTELLIGENCE IN LIFE SCIENCES -
Life sciences companies are forming AI-driven strategic collaborations with tech giants, creating synergy that promises to revolutionize the industry. Companies like NVIDIA,...more
8/20/2024
/ Algorithms ,
America Invents Act ,
Artificial Intelligence ,
Bayh-Dole Act ,
Chevron Deference ,
Healthcare ,
Inflation Reduction Act (IRA) ,
Innovative Technology ,
Intellectual Property Protection ,
Life Sciences ,
Machine Learning ,
March-in-Rights ,
NIST ,
Non-Compete Agreements ,
Patents ,
Post-Grant Review ,
Prior Art ,
USPTO
Summary -
A recent ruling on a motion to dismiss in a shareholder putative class action, brought by an investor against software company Pegasystems (Pega) in the District of Massachusetts, should give legal leaders and...more
SUMMARY -
On December 1, 2020, The Nasdaq Stock Market filed a proposed rule with the U.S. Securities and Exchange Commission (SEC), which, if approved, will require listed companies to disclose the racial, LGBTQ+ status,...more
In light of the ongoing COVID-19 pandemic, most colleges and universities have moved to online learning for the remainder of the school year with the potential for continuing in to the Fall semester. Schools have taken...more
In a partial victory for the NCAA, the Ninth Circuit Court of Appeals overturned in part a permanent injunction issued by the District Court for the Northern District of California, which had required the NCAA to allow...more
10/1/2015
/ Basketball ,
Class Action ,
College Athletes ,
Colleges ,
Deferred Compensation ,
Educational Institutions ,
Football ,
Name and Likeness ,
NCAA ,
Permanent Injunctions ,
Scholarships ,
Student Athletes ,
UCLA ,
Universities ,
Wage and Hour
Last week, a federal judge ruled that the Food and Drug Administration (FDA) cannot prohibit a pharmaceutical company from marketing its drugs for off-label uses if its claims are truthful and not misleading. This ruling,...more
The California Supreme Court issued a decision today in the Cipro antitrust cases, concluding that the analysis set forth by the U.S. Supreme Court in FTC v. Actavis applies to alleged “pay-for-delay” pharmaceutical patent...more
For the first time within the Third Circuit, a court has added to the handful of decisions holding that the attorney-client privilege does not shield an antitrust compliance policy from disclosure in antitrust litigation. In...more
A recent California federal court decision has further lifted the thumb on the scales that has historically benefited collegiate athletics in weighing whether their association rules violate the federal antitrust laws. ...more
8/11/2014
/ Antitrust Provisions ,
College Athletes ,
Colleges ,
Corporate Counsel ,
Injunctions ,
License Agreements ,
NCAA ,
Price-Fixing ,
Recruitment Incentives ,
Recruitment Policies ,
Revenue Sharing ,
Universities
The U.S. Supreme Court issued its much-anticipated opinion today in FTC v. Actavis, Inc., ruling that so-called “reverse payment” patent settlements between innovator and generic pharmaceutical manufacturers that are...more